1 Malet-Martino M, Jolimaitre P, Martino R. The prodrugs of 5-fluorouracil[J]. Curr Med Chem Anticancer Agents, 2002, 2(2): 267-310.
[2]
2 Yokoyama T, Hosoya Y, Aoki T, et al. Angina attack caused by 5-fluorouracil infusion--report of a case and review of the literature[J]. Gan To Kagaku Ryoho, 2002, 29(10): 1805-1808.
9 Wacker A, Lersch C, Scherpinski U, et al. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients[J]. Oncology, 2003, 65(2): 108-112.
11 Abou El Fadl MH, Bagai RK, Spiro TP, et al. 5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel[J]. Gastrointest Cancer Res, 2009, 3(4): 167-170.
[12]
12 Talapatra K, Rajesh I, Rajesh B, et al. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil[J]. J Cancer Res Ther, 2007, 3(3): 169-171.
[13]
13 Tsavaris N, Kosmas C, Vadiaka M, et al. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients[J]. Med Sci Monit, 2002, 8(6): PI51-PI57.
[14]
14 Sabri B, Ceyhun C, Nezih M, et al. A new perspective on cardiotoxicityof 5-fluorouracil[J]. Pharmacology, 2004, 50(3): 113-118.
